Preparing for China · patient guide

Liver Cancer Care in China: What the Diagnosis Report Should Clarify

A useful liver cancer diagnosis report should state the tumour's location, size and extent, whether the cancer has spread, how well the liver is still working, and what treatment has already been given. Those four points decide whether a China hospital can assess surgery, ablation, radiotherapy or systemic therapy, and they are the first things a multidisciplinary team needs.

Go to the practical guidance ↓
AI illustration: A healthcare professional discusses medical documents with a patient in a consultation room.
AI-generated illustration for care planning; not a photograph of a real patient, clinician or hospital, and not a diagnostic image.
In this guide

Why the diagnosis report, not the scan alone, drives the decision

A scan image without a written report is hard for a new hospital to act on. The report is the document that turns images and laboratory values into a clinical statement: what the lesion is, where it sits, how it relates to vessels and bile ducts, and whether there is evidence of spread. When you send records to a hospital in China, the receiving clinician is reading a summary of your case, not repeating your original workup.

This matters because liver cancer decisions are not made from one number. A tumour may look removable on imaging but sit next to a major vessel. Liver function may be too impaired for a major operation even when the tumour is small. Previous treatment may have changed what is technically possible. A report that omits these points forces the new team to ask for more, which slows the assessment.

The practical goal is not a perfect file. It is a file that answers the questions a multidisciplinary team will ask in its first meeting. If you know which questions those are, you can check your own report before you send it.

Tumour description: what the report should state

The tumour section should identify the number of lesions, the size of each, and the segments of the liver involved. It should say whether the tumour is confined to the liver or has grown into nearby structures, and whether imaging shows involvement of the portal vein or other major vessels. It should also state whether there is evidence of spread outside the liver, and where.

These details matter because they change the treatment conversation. A single small lesion in one part of the liver raises different options from multiple lesions in both lobes. Vascular involvement can make some operations unsafe. Extrahepatic disease shifts the focus toward systemic treatment rather than local removal. None of this is a recommendation; it is the information a specialist uses to decide what to discuss with you.

If your report uses a staging system, note which one and what stage was assigned. If it does not, ask whether a stage has been recorded. A stage without the underlying description is less useful than the description itself.

  • Number of lesions and size of each
  • Liver segments involved
  • Relationship to major vessels and bile ducts
  • Evidence of spread outside the liver
  • Staging system used, if any

Liver function: the record that decides what is safe

Liver cancer often develops in a liver that is already damaged. The diagnosis report should therefore include the results that describe how well the liver is working: bilirubin, albumin, clotting studies, platelet count and any record of ascites or encephalopathy. If a fibrosis or cirrhosis assessment has been done, the result belongs in the summary.

This is not background detail. Two patients with similar tumours can face very different options because one liver tolerates treatment and the other does not. A receiving team needs to know whether the liver reserve is preserved, borderline or poor, because that assessment shapes whether surgery, ablation, radiotherapy or systemic therapy is even worth discussing.

The reason liver function carries so much weight is that the liver has to keep working during and after any treatment. An operation removes part of it. Ablation and embolisation disturb a region of it. Systemic therapy is processed by it. Radiotherapy directed at the liver is planned around it. If the reserve is already thin, the same tumour that looks treatable in one patient may be unsafe to treat aggressively in another, and the report is where that difference becomes visible.

Dates matter as much as values. A bilirubin result from six months ago says little about today, especially if treatment has happened since. Where possible, the summary should show the most recent set of liver-function results alongside the earlier ones, so the receiving team can see the direction of travel rather than a single snapshot. A rising trend and a stable trend can lead to different questions even when the latest number is identical.

If your records include a score such as Child-Pugh or MELD, include it with the date. If they do not, ask your treating clinician whether one has been calculated. Do not calculate it yourself from partial results.

It also helps to note anything that affects how those results should be read. If you are taking a medicine that influences clotting or liver enzymes, if you have had a recent infection, or if a bile duct has been stented, that context belongs in the summary. Without it, a receiving clinician may interpret a value differently from your own team, and the first multidisciplinary discussion can stall on a question that a single line of context would have answered.

Finally, separate the liver-function record from the tumour record in your own file. When the two are mixed together, it is easy to send one and forget the other. Keeping them as two clearly labelled groups makes it obvious at a glance whether both have been included, and it gives the receiving team the two halves of the picture they need to begin.

Previous local treatment: what was done, when and with what result

If you have already had treatment, the report should say what it was, when it was given, and what the follow-up imaging showed. This includes surgery, ablation, embolisation, radiotherapy or systemic therapy. For each, the key question is whether the treated area is now stable, smaller, unchanged or growing.

This history changes the options a new team can consider. A liver that has already had part removed has less reserve. A tumour that progressed after one systemic therapy may be considered for a different regimen. A lesion that recurred after ablation may be approached differently the second time. Without dates and outcomes, the new team cannot tell whether you are responding, stable or progressing.

Bring the actual treatment summary, not only the discharge note. If the summary is in another language, ask whether a translated clinical summary can be prepared. A translation of the full file is not always necessary; a clear summary of treatment and response often is.

What a multidisciplinary review adds, and what it cannot confirm

Liver cancer sits between several specialties: hepatobiliary surgery, medical oncology, interventional radiology, radiotherapy and hepatology. A multidisciplinary review brings these perspectives together so that the options are considered side by side rather than one at a time. For a complex case, that is often the most useful first step after the records are complete.

A records-based review can clarify how your case looks to a specialist team, which questions remain open, and what further information would help. It cannot confirm that you are a candidate for a specific operation, that a particular treatment is available to you, or that a hospital will accept your case. Those decisions belong to the treating team after they have seen you and any additional tests they require.

Radiotherapy is one example of why this distinction matters. It uses radiation to treat cancer, and the technique and schedule depend on the individual treatment plan. A review can discuss whether radiotherapy is worth assessing, but the plan itself is made by the treating clinicians with you.

Preparing the file and the questions to ask before you travel

Start with a short summary: diagnosis, date, stage if recorded, liver function results, previous treatment and current question. Then attach the supporting reports in a logical order. You do not need to send your entire archive at first contact. A brief summary lets the receiving team tell you what else they need.

Before committing to travel, ask the hospital or coordinator what their written assessment includes, who reviews the records, and what they can and cannot confirm remotely. Ask whether a video or in-person visit is required before any treatment decision, and what records they still need. Ask how the estimate is structured and what it covers, so you can compare like with like.

Keep your own copy of everything you send. If a report is missing a key point, ask your current clinician to add a short clarifying note rather than repeating the whole workup. If your symptoms worsen, seek local care first; an overseas enquiry should not delay urgent assessment.

ChinaSpecialistCare can review a short summary, identify what is missing and suggest the relevant next step. An initial enquiry is free and does not require buying a proxy consultation. The hospital decides suitability.

  • Diagnosis and date
  • Stage, if recorded
  • Liver function results with dates
  • Previous treatment and response
  • Current question you want answered

Related treatment reference

Sources & scope of this guide

References and official service information relevant to this guide.

  1. oncology
  2. Related treatment reference
  3. NCI: Radiation Therapy for Cancer

This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.